-
Hualu Company and Longji Co., Ltd. cooperate to develop green hydrogen
Time of Update: 2021-09-12
The two parties will establish a strategic partnership around the transformation of green hydrogen energy technology and scientific and technological achievements, strengthen strategic cooperation in the application of green hydrogen and coal chemical coupling scenarios, new energy-related industries, high-end equipment R&D and procurement, etc.
-
Baoti Co., Ltd. (SH: 600456): A listed company with the largest market share of titanium in the domestic market
Time of Update: 2021-07-30
issued an announcement that due to the continuous expansion of downstream applications such as aerospace, ships, marine, nuclear power, and chemical industries, the company's existing high-end titanium product capacity utilization rate is close to saturation, and it can no longer meet current needs.
-
, and many companies such as Amgen, Novartis, Betta Pharmaceutical Co., Ltd. are deployed
Time of Update: 2021-06-30
The Phase II study CodeBreaK 100 data on which its marketing application is based shows that sotorasib exhibits long-lasting anti-tumor activity in advanced NSCLC patients with KRAS G12C mutation who have previously received chemotherapy and/or PD-1/PD-L1 immunotherapy.
-
Lomon Baili: The company has established a new company and acquired Henan Zhongtan New Materials Co
Time of Update: 2021-06-16
Does your company have such an arrangement?
Does your company have such an arrangement?
The company replied, hello!
The company replied, hello!
The company has established Henan Baili New Energy Company, Henan Longbai New Material Company, and acquired Henan Zhongtan New Material Company, specializing in the research and development and industrialization of new energy battery materials .
-
Aitubang member company Runtai Co., Ltd. ranks among the top 100 Sinopec private enterprises in 2018!
Time of Update: 2021-05-01
With the purpose of innovation, Runtai Chemicals continuously develops new products and services to meet the needs of the coatings market and cope with many challenges facing the world.
-
Huiyun Titanium Industry Co., Ltd. was awarded 2.5 million yuan in the promotion meeting of the company's listing work held in our city
Time of Update: 2021-04-28
Huiyun Titanium was listed on the Growth Enterprise Market of the Shenzhen Stock Exchange in September 2020, becoming the second listed company in the city.
-
Vietnam Dairy Products Co., Ltd. rises 6 places in the top 50 dairy companies in the world
Time of Update: 2021-04-22
According to statistics from two market research companies, Nielsen and Kantar Worldpanel, Vietnam Dairy Products Corporation has successfully maintained its position as the number one brand in the Vietnamese dairy industry, and is the brand that Vietnamese consumers have chosen to buy the most for eight consecutive years.
-
Aitubang member company Runtai Co., Ltd. ranks among the top 100 Sinopec private enterprises in 2018!
Time of Update: 2021-03-29
With the purpose of innovation, Runtai Chemicals continuously develops new products and services to meet the needs of the coatings market and cope with many challenges facing the world.
-
Huiyun Titanium Industry Co., Ltd. was awarded 2.5 million yuan in the promotion meeting of the company's listing work held in our city
Time of Update: 2021-03-27
Huiyun Titanium was listed on the Growth Enterprise Market of the Shenzhen Stock Exchange in September 2020, becoming the second listed company in the city.
-
Zuoli Pharmaceutical Co., Ltd.: Coji Pharmaceutical Co., Ltd., a joint stock company, submits a listing application to the Hong Kong Stock Exchange
Time of Update: 2021-03-24
, a joint stock company, CARsgenTherapeutics Holdings Limited (hereinafter referred to as "Keji Pharmaceutical"), issued a transaction to the Hong Kong Stock Exchange on February 26, 2021.
On the same day, the website of the Hong Kong Stock Exchange published the application materials for the issuance and listing of Keji Pharmaceutical.
-
It is expected that Yang Luhan co-founded a company for transplanting pig organs and received US$125 million in assistance
Time of Update: 2021-03-23
Today, eGenesis, which is committed to developing organs, tissues and cells compatible with humans, announced that it has completed a $125 million Series C financing.
eGenesis is committed to solving the above problems and developing organs, tissues and cells compatible with humans.
-
"Pharmaceutical Express" Mercadon and Seattle co-operation well-known pharmaceutical companies to buy six varieties
Time of Update: 2020-11-03
September 15, 2020 / Medical Information At a Glance: Blainger Ingham and Click collaborated in the development and commercialization of CT-155; JAK inhibitors/Redsivir combination therapy reached phase 3 clinical endpoints; Sanofi/regenerative dupixent treatment of acidic granulocytic esophagealitis was recognized by the FDA breakthrough therapy; assapen Pharmaceuticals 3 products were eligible for FDA orphan drugs...
-
The chairman and general manager of Sichuan Fuzheng Pharmaceutical Co., Ltd., a well-known pharmaceutical company, resigned.
Time of Update: 2020-08-30
On August 20th, Sichuan Fuzheng Pharmaceutical Co., Ltd. announced the resignation of its chairman and general manager, saying that on August 10th the company's board of directors received a resignation report from Sun Jilin, chairman of the board of directors, effective August 10, 2020.
-
Accelerate the development of the COVID-19 vaccine! Co-operation among pharmaceutical companies is crucial.
Time of Update: 2020-08-03
In the animal model of SARS-CoV-1, the use of recombinant sub-proteins against viruses, nucleic acid-vector vaccines, and the passive transfer of neutralizing antibodies to the stingproteins have been shown to be protective of experimental infections.
-
The Anniversary of the Co-E-Plate . . . Pharmaceutical stock market value TOP10 announced waiting for listed companies to source concentration
Time of Update: 2020-07-09
On June 13, 2019, the board officially opened, and it has been the first anniversary During the year, 67 biopharmaceutical companies have filed for listing, 26 have successfully launched their ipos, a